Kyverna Therapeutics (KYTX) Stock Price & Financial Analysis
Kyverna Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Kyverna Therapeutics
What is the current stock price for KYTX?
As of the latest trading session, KYTX stock trades at $8.62. The 52-week range is $2.52–$13.67, with a day range of $8.35–$8.65.
What is the P/E ratio for KYTX?
The P/E ratio (Price-to-Earnings) for KYTX is shown in the Key Statistics section. This valuation metric helps compare Kyverna Therapeutics, Inc. to industry peers.
Does KYTX pay dividends?
Kyverna Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for KYTX?
Based on 6 analysts, the consensus for KYTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of KYTX?
Kyverna Therapeutics's market capitalization is $520.9M, classifying it as a small-cap company. Kyverna Therapeutics operates in the Healthcare sector within the Biotechnology industry.